Dalradian Resources (DNA) Stock Price, News & Analysis

Company Overview

Dalradian Resources Inc. engages in the acquisition, exploration, evaluation, and development of mineral properties. The company explores for gold and silver ores. It primarily focuses on the development of Curraghinalt project in Northern Ireland, the United Kingdom. The company was formerly known as SA Resources Inc. and changed its name to Dalradian Resources Inc. in April 2010. Dalradian Resources Inc. was incorporated in 2009 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$1.46 to C$1.47
• 50-Day Range: C$1.46 to C$1.46
• 52-Week Range: C$0.89 to C$1.65
• Volume: 174,004 shs
• Average Volume: 530,457 shs
• Market Capitalization: C$519.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DNA Stock Analysis - Frequently Asked Questions

How have DNA shares performed this year?

Dalradian Resources' stock was trading at C$1.46 on January 1st, 2024. Since then, DNA stock has increased by 0.0% and is now trading at C$1.46.
View the best growth stocks for 2024 here.

How do I buy shares of Dalradian Resources?

Shares of DNA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Dalradian Resources own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dalradian Resources investors own include Osisko Mining (OSK), Dalradian Resources (DALR), Excellon Resources (EXN), Jazz Pharmaceuticals (JAZZ), Sandstorm Gold (SSL), Fortuna Silver Mines (FSM) and Pretium Resources (PVG).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Basic Materials
• Industry: Gold
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:DNA
• CUSIP: N/A
• CIK: N/A
• Web: www.dalradian.com
• Phone: +1-416-5835600
• Fax: N/A
• Employees: 640
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 17.64
• Quick Ratio: 17.56

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.34 per share
• Price / Cash Flow: 4.32
• Book Value: C$0.84 per share
• Price / Book: 1.74

Miscellaneous

• Outstanding Shares: 355,493,000
• Free Float: N/A
• Market Cap: C$519.02 million
• Optionable: Not Optionable
• Beta: N/A